Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$96.99M
Current Assets
2022 Q3
$35.37K
Current Liabilities
2022 Q3
Current Ratio
2022 Q3
15.6%
Total Assets
2022 Q3
Total Liabilities
2022 Q3
Book Value
2022 Q3
-$191.3K
Cash
2022 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $10.864 Million

About NUNZIA PHARMACEUTICAL Co

Nunzia Pharmaceutical Corp. engages in the manufacture and sales of drugs. The company is headquartered in Los Angeles, California. The firm manufactures, markets and plan to distribute Nunzia, direct to consumers through its website, www.nunziapharma.com, and through wholesalers. Nunzia is nutraceutical product is designed to treat the symptoms of these wide-ranging medical conditions. Nunzia product is intended to increase sensory, social, and daily living skills, as well as increasing attention span, memory retention, focus, comprehension and learning while decreasing anxiety, stress, fixations, fidgeting and outside detractions.

Industry: Medicinal Chemicals & Botanical Products Peers: Bonk Inc Integrated Biopharma Inc MAKINGORG, INC. Estee Lauder Companies Inc High Sierra Technologies, Inc. Zivo Bioscience Inc Mannatech Inc TWINLAB CONSOLIDATED HOLDINGS, INC. REVLON INC /DE/

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support